AI firm Lunit is implementing its AI-powered breast cancer detection software, Lunit Insight MMG, in Qatar’s national breast cancer screening program.

Qatar’s Primary Health Care Corporation (PHCC) has integrated Lunit Insight MMG into its “Screen for Life” program, the country’s national breast and bowel cancer screening initiative. The deployment aims to improve early detection of breast cancer, potentially reducing missed diagnoses and improving survival rates in Qatar’s triennial screening program, according to the vendor. The partnership is set for an initial period of five years.

The implementation follows a successful retrospective validation phase that began in March 2023, Lunit said. Two radiologists now read each mammogram while referring to Insight MMG’s results, according to the firm.

Lunit said the partnership is part of a broader trend of the company’s expansion in business-to-government (B2G) cancer screening initiatives worldwide. The company recently brought Insight MMG to screening programs and hospitals in Australia, Sweden, Saudi Arabia, and Iceland.